Rajeev M. Shah, Director, 10% Owner at Satsuma Pharmaceuticals, Inc. (STSA), bought 2,464,788 shares at $5.68 ($14.0M) on 2021-02-26, disclosed to the SEC on 2021-03-02.
Open-market purchase of $14.0M STSA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.68 | 1,232,394 | $7.0M | 50.0% |
| 2 | $5.68 | 1,232,394 | $7.0M | 50.0% |
| Total | $5.68 avg | 2,464,788 | $14.0M | 100% |
| Filing → |
| SEPN | BUY | 2024-10-30 | $75.1M | — | Filing → |
| AVTE | BUY | 2024-06-20 | $3.1M | — | Filing → |
| HOWL | BUY | 2023-01-10 | $4.1M | — | Filing → |